The yeast PKAN model that recapitulates the most important phenotypes found in PKAN patients could represent a powerful tool for the searching of a chemical suppressor i.e., a potential therapeutic drug for PKAN. The gene discussed is PANK2; the disease is pantothenate kinase-associated neurodegeneration.